2023 International Congress Archives - Page 6 of 186

Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations

F. Bernasconi, J. Pagonabarraga, H. Bejr-Kasem, S. Martinez-Horta, J. Marín-Lahoz, A. Horta-Barba, J. Kulisevsky, O. Blanke (Geneva, Switzerland)
Early cortical atrophy is related to depression in Parkinson’s disease

E. Backman, L. Saari, R. Parkkola, J. Lötjönen, M. Gardberg, V. Kaasinen (Turku, Finland)
Early functional disruption in body-first compared to brain-first Parkinson’s disease

M. Conti, R. Bovenzi, R. Cerroni, T. Schirinzi, M. Pierantozzi, N. Mercuri, A. Stefani (Rome, Italy)
Early neurotransmitters changes in Parkinson’s disease with REM sleep behaviour disorder

D. Urso, B. Tafuri, S. Nigro, V. Gnoni, I. Rosenzweig, K. Ray Chaudhuri, G. Logroscino (Tricase, Italy)
Early onset of efficacy during titration in US phase 3 open-label InfusON trial of apomorphine subcutaneous infusion for Parkinson’s disease motor fluctuations

S. Isaacson, G. Ceresoli-Borroni, A. Espay, R. Pahwa, P. Agarwal, H. Shill, J. Hui, K. Dashtipour, M. Lew, P. Qin, P. Lewitt (Boca Raton, USA)
Early versus late levodopa administration in Parkinson’s disease: Comparative study

A. Akid, I. Kacem, A. Guedi, Y. Abida, S. Mrabet, A. Souissi, A. Gharbi, A. Nasri, R. Gouider (Tunis, Tunisia)
Early-onset cortico-basal degeneration (CBD) due to a c.2092G>A MAPT mutation

M. Mata Alvarez-Santullano, L. Lopez-Manzanares, J. Lopez-Lozano, N. Villares, C. Magdaleno, C. Dela Torre (Madrid, Spain)
Early-onset levodopa-responsive Parkinsonism associated with dysarthria, pyramidalism, and dystonia: a rare condition that can benefit from a combined treatment approach.

L. Gallo, M. Avenali, P. Mitrotti, C. Tassorelli, R. Zangaglia, F. Valentino, S. Gana, EM. Valente, C. Pacchetti, G. Cosentino (Pavia, Italy)
Early-onset spastic ataxia in a patient with prion (PRNP) p.Val180Ile mutation

SM. Lee, DY. Yoo, TB. Ahn (Seoul, Republic of Korea)
Early-phase 18F-FP-CIT PET images: a promising imaging biomarker for predicting early dementia conversion in Parkinson’s disease

SJ. Chung, MY. Chun, T. Lee, SH. Kim, HS. Lee, YJ. Kim, PH. Lee, Y. Jeong, YH. Sohn (Yongin-si, Republic of Korea)
Education and the motor effects of dopamine loss in Parkinson’s disease

M. Hoenig, V. Dzialas, M. Banwinkler, A. Asendorf, T. van Eimeren (Juelich, Germany)
Education level and the onset and severity of symptoms in Huntington’s disease

SR. Zhang, YF. Cheng, XJ. Gu, KC. Liu, JY. Lin, TM. Yang, Y. Xiao, QR. Jiang, JX. Huang, QQ. Wei, RW. Ou, YB. Hou, LY. Zhang, CY. Li, JM. Burgunder, HF. Shang (Chengdu, China)
Effect and Mechanism of Shaoyao Gancao Decoction(SGD) in Treatment of Pain in Parkinson’s Disease Based on Network Pharmacology and Molecular Docking

Q. Zhao (Shanghai, China)
Effect of ADX-88178, a highly-selective mGlu4 PAM, on parkinsonism, dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

I. Frouni, C. Kwan, D. Bédard, W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)
Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)
Effect of deep brain stimulation on dysphagia in Parkinson’s disease: A Systematic Review

A. Rossato, L. Aires, L. Lobato, V. Müller, H. Rodrigues, C. Menegon, V. de Souza, G. Maia, L. Fernandez (Porto Alegre, Brazil)
Effect of Deep Brain Stimulation on the Motor Profile of Parkinson’s Disease in Egypt; A Developing Country Experience

S. Abdelaziz, A. Shalash, E. Hamid, Z. Yossry, M. Alkarras, D. Elheraby, Y. Salah, M. Essam, H. Radwan (Cairo, Egypt)
Effect of dietary caffeine on brain dopamine transporter binding in Parkinson’s disease

E. Saarinen, T. Kuusimäki, K. Lindholm, EA. Honkanen, T. Noponen, M. Seppänen, K. Murtomäki, T. Mertsalmi, E. Jaakkola, E. Mäkinen, M. Eklund, S. Nuuttila, R. Levo, KR. Chaudhuri, A. Antonini, J. Joutsa, F. Scheperjans, V. Kaasinen (Turku, Finland)
Effect of differences in stomach and small intestine pH on response to levodopa in patients with Parkinson’s Disease.

M. Arena, B. Brumbach, S. Diamond, K. Block, J. Nutt, R. Pfeiffer, D. Safarpour (Portland, USA)
Effect of intensive Game-based neurorehabilitation (GBNR) on gait, balance and quality of life (QOL) in Parkinson’s patients: A prospective randomized control study

R. Savaj, P. Vengurlekar, C. Sankhla, S. Patel (Mumbai, India)
Effect of levodopa on the interpretation of social interactions in people living with Parkinson’s disease

T. Danaila, E. Metereau (Bron, France)
Effect of lower level laser therapy for neurogenic or non-neurogenic overactive bladder

T. Uchiyama, T. Yamamoto, R. Sakakibara, S. Kuwabara, H. Murai (Chiba, Japan)
Effect of multi-strain probiotics on gut microbiome and metabolites in Parkinson’s Disease

JW. Hor, SY. Lim, CW. Chong, SL. Song, CSJ. Teh, TS. Toh, JL. Lim, KY. Khaw, AH. Tan (Kuala Lumpur, Malaysia)
Effect of Recognition of Vertical Posture on Forward Bending Posture in Patients with Parkinson’s Disease: A Multicenter Observational Study

M. Shiraishi, K. Mikami, H. Kamo, T. Kamo, T. Tsunemi, Y. Okuma, K. Fujimoto, Y. Yokota, S. Nogawa, T. Osada, M. Seki, H. Nagayama, T. Hatano, H. Nakajima, K. Suzuki, T. Yamamoto, Y. Yamano, N. Hattori, M. Ijima (Kawasaki, Japan)
Effect of Sex on the association between GBA mutations and Cognitive Decline in Parkinson’s Disease

SP. Caminiti, M. Avenali, M. Inglese, C. Tassorelli, D. Perani (Pavia, Italy)
Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)
Effect of the COVID-19 pandemic on gait and other motor and non-motor symptoms in people with Parkinson’s disease

A. Boddu, A. Glover, L. Pillai, T. Virmani (Little Rock, USA)
Effect of variants in COMT and UGT1A genes on clinical response in patients with Parkinson’s disease treated with opicapone

E. Ojeda-Lepe, S. García-Díaz, R. Díaz Belloso, L. Muñoz-Delgado, S. Jesús, MT. Periñán, B. Benítez Zamora, AD. Adarmes-Gómez, D. Macías-García, M. Martín-Bornez, M. Bonilla-Toribio, D. Buiza-Rueda, R. Pineda-Sánchez, F. Carrillo, P. Gómez-Garre, P. Mir (Seville, Spain)
Effect of ventricular morphometrics on the treatment of Parkinson’s disease

JJ. Lee, YB. Yong, JS. Baik (Goyang-si, Republic of Korea)
Effectiveness of at home, repeated transcranial pulse current stimulation (tPCS) sessions for treatment of neurodegenerative ataxia.

G. Prado- Miranda, D. Aur, D. Babiker, M. Jog (London, On, Canada)
Effectiveness of core muscle exercise training for Parkinson’s disease patients with trunk side-bending

JC. Hsu, YC. Chein, KH. Chen, HY. Chen, HT. Tsai, YH. Chen (Hsinchu city, Taiwan)
Effectiveness of deep brain stimulation in the treatment of Huntington’s disease

H. Rodrigues, G. Mantovani, M. da Rosa, V. de Souza, L. Aires, M. Fin, L. Lobato, R. Albuquerque, PL. da Silva, A. Hilbig (Porto Alegre, Brazil)
Effectiveness of non-invasive therapy of tPCS & peripheral nerve stimulation on Ataxia patients

D. Heng, C. Chen, X. Choi, E. Lim, G. Chia, W. Li, K. Narasimhalu, P. Kumar, Y. Lo, E. Tan (Singapore, Singapore)
Effectiveness of speech therapy in patients with Parkinson’s disease – a randomized controlled trial

J. Maas, N. de Vries, B. Bloem, H. Kalf (Nijmegen, Netherlands)
Effectiveness of trampoline training on non-motor outcomes in people with Parkinson’s: preliminary study results

J. Domingos, J. Gomes, J. Dean, J. Fernandes, J. Vaz, C. Godinho (Monte da Caparica, Portugal)
Effectiveness of use of Pictographs on Levodopa packaging to ensure awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease.

M. Matta, N. Sawal (Chandigarh, India)
Effects and neural mechanisms of training involving rhythmic auditory stimulation on upper-limb movements in patients with Parkinson’s disease

W. Fan, K. Fong, S. Wang (Hong Kong, China)
Effects of a nurse-led Advance Care Planning and Care Coordination intervention in Parkinson’s Disease – patient and family caregiver perspectives from a multicentre European study

C. Muente, BW. Dijkstra, CM. Groot, MJ. Meinders (Nijmegen, Netherlands)
Effects of a rhythmic auditory stimulation-enhanced walking program on Veterans with Parkinson’s disease with and without subthalamic nucleus deep brain stimulation.

A. Umbarger, S. Kletzel, S. Walker, C. Jelinek, C. Kestner, K. Krese, B. Mcreavy, T. Bender Pape, F. Weaver, K. Colletta (Gary, USA)
Effects of a small molecule angiotensin IV analog on Huntington’s disease animal model

R. Wells, A. Azzam, A. Hiller, M. Sardinia (Portland, USA)
Effects of an online 12-week Tai Chi intervention on gait and postural stability in individuals with Parkinson’s disease

NY. Law, JX. Li (Ottawa, Canada)
Effects of ankle dorsiflexion training on anticipatory postural adjustments during gait initiation of patients with Parkinson’s disease

A. Nagai, M. Okinishi, T. Kozuki, K. Ohata, S. Takasaki, H. Kojima, K. Marumoto (Hyogo, Japan)
Effects of Boxing and conventional physiotherapy techniques in patients with PD: A randomized control study

W. Kamel, M. Asala, A. Al-Tajalli, A. Al-Tammar, R. Alkhaldi, C. Ramos Jr, A. Mubarak (beni suef, Egypt)
Effects of cerebellar cTBS on motor symptoms in Huntington’s disease: a feasibility and pilot study

JF. Martin Rodriguez, M. Gomez Crespo, FJ. Gómez Campos, AM. Castellano-Gerrero, V. Villarreal, FJ. Palomar Simón, P. Porcacchia, F. Carrillo, S. Jesús, P. Mir (Sevilla, Spain)
Effects of cerebellar theta burst stimulation on working memory in Parkinson’s disease

N. Raies, J-F. Nankoo, T. Grippe, R. Chen (Toronto, Canada)
Effects of combined subthalamic and dorsolateral nigral deep brain stimulation on gait performance in Parkinson’s Disease

D. Kroneberg, B. Al-Fatly, C. Morkos, GH. Schneider, A. Kühn (Berlin, Germany)
Effects of Eromomastax speciosa in a Gastric Ulcer in a 6-hydroxydopamine (6-OHDA)-induced Rat Model of Parkinson’s Disease.

GL. Ndji Otto, P. Amang, H. Adjia (Bertoua, Cameroon)
Effects of exergaming-based tai chi and eye movement training on balance and gait in progressive supranuclear palsy: a case report

Y. Levitan-Marcus (Tel Aviv, Israel)
Effects of GBA1 mutations and STN-DBS on response inhibition in Parkinson’s disease

A. Almelegy, S. Gunda, S. Buyske, M. Rosenbaum, S. Sani, M. Afshari, L. Metman, C. Goetz, D. Hall, M. Mouradian, G. Pal (New Brunswick, USA)
Effects of intermittent theta burst stimulation over primary motor cortex on functional connectivity in Parkinson’s disease patients

G. Kotsoev, E. Fedotova, E. Kremneva, I. Bakulin, A. Poydasheva, N. Suponeva (Moscow, Russian Federation)
Effects of mirror therapy on walking ability in patients with chronic stroke: a randomized controlled study

W H. Weng, R Y. Wang, Y R. Yang (Taipei, Taiwan)
Effects of motor and cognitive complex training on obstacle-crossing ability in participants with Parkinson’s disease

R Y. Wang, C W. Hung, Y R. Yang (Taipei, Taiwan)
Effects of Motor Subtype Stability on Non-Motor Symptoms in Early Parkinson’s Disease

S. Ng, N. Chia, X. Choi, D. Heng, S. Neo, ZY. Xu, KY. Tay, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)
Effects of NE3107 anti-inflammatory treatment on motor activity and neurodegenerative features of Parkinson’s disease in a marmoset monkey model

I. Philippens, C. Ahlem, C. Reading (Antwerp, Belgium)
Effects of physical exercise interventions on cognitive function in Parkinson’s disease: an updated systematic review and meta-analysis of randomized controlled trials

R. Kim, JS. Jun, N. Kang (Incheon, Republic of Korea)
Effects of sling exercise in people with chronic stroke – the emphasis of core muscle control on gait

CY. Chiu, RY. Wang, WC. Chen (Taipei City, Taiwan)
Effects of Subthalamic Nucleus Deep Brain Stimulation on Phase Amplitude Coupling in Parkinson’s disease

A. Bhattacharya, JF. Nankoo, N. Drummond, K. Udupa, A. Lozano, M. Hodaie, S. Kalia, A. Fasano, R. Munhoz, A. Lang, R. Chen (Toronto, Canada)
Effects of thalamic deep brain stimulation on focal hand dystonia

T. Hashimoto, J. Tanimura, T. Yako (Matsumoto, Japan)
Effects of theta burst transcranial ultrasound stimulation on motor cortex excitability in Parkinson’s disease.

T. Grippe, Y. Shamli Oghli, G. Darmani, JF. Nankoo, N. Raies, C. Sarica, T. Arora, C. Rinchon, C. Gunraj, F. Cardoso, R. Chen (Toronto, Canada)
Effects of Unilateral and Bilateral DBS of STN, GPi on Voice in PD Patients

M. Siddiqui, S. Naing, K. Ruckart, R. Hayes, L. Jafri, M. Moya-Mendez, L. Madden, J. Tate (Winston-Salem, USA)
Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)
Efficacy and safety of adjunctive oral therapy in Parkinson’s disease with motor complications: a systematic review and network meta-analysis

V. Sisodia, L. Dubbeld, RMA. de Bie, GS. Duarte, J. Costa, JM. Dijk (Amsterdam, Netherlands)
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicentre, parallel, randomised, double blind, phase 2b clinical trial

C. Laurencin, A. Marques, D. Dilly Duchez, C. Giordana, S. Meoni, M. Anheim, P. Boulinguez, B. Ballanger, S. Thobois (Lyon, France)
Efficacy and safety of deutetrabenazine in children and adolescents with dyskinesia in cerebral palsy

D. Claassen, L. Dure, H. Barkay, S. Barash, G. Yiu, L. Voisin, L. Marinelli, P. Moshkov, J-M. Savola, M. Chen, N. Chaijale, M. Gordon, A. Ahn (Nashville, USA)
Efficacy and safety of foslevodopa/foscarbidopa continuous subcutaneous infusion administered as monotherapy in patients with Parkinson’s disease

J. Aldred, T. Henriksen, M. Bouchard, J. Martínez-Castrillo, M. Soileau, A. Spiegel, L. Bergmann, R. Gupta, P. Kukreja, D. Standaert (Spokane, USA)
Efficacy and safety of Mexiletine versus Placebo in patients with myotonia: A Systematic Review and Meta-analysis

A. Elettreby, A. Abo Elnaga, M. Alsaied (Mansoura, Egypt)
Efficacy and safety of safinamide in PD patients over 70 years vs. under 70 years old;

A. Ferreira, M. Rodrigues (Braga, Portugal)
Efficacy of a four-strain probiotic on gut dysbiosis, motor and non-motor symptoms in Parkinson`s disease: a multicentre randomised controlled trial

V. Leta, P. Zinzalias, J. Staunton, L. Batzu, D. Trivedi, F. Jernstedt, K. Rosqvist, J. Timpka, T. van Vliet, A. Podlewska, M. Parry, D. van Wamelen, A. Rizos, G. Chung-Faye, A. Borsini, C. Pariante, P. Odin, K. Ray Chaudhuri (London, United Kingdom)
Efficacy of emergency deep brain stimulation in the Globus pallidus pars interna (GPi-DBS) for dystonic storm in an adult patient with de novo GNAO1-Mutation

V. Maltese (Würzburg, Germany)
Efficacy of levodopa/carbidopa/entacapone replacement of levodopa/dopa decarboxylase inhibitors in treatment of Chinese Parkinson’s disease patients with wearing-off: a multicenter, randomized controlled, open label study

CY. Yu, WG. Liu, AP. Gong, LH. Shen, H. Huang, Y. Zhao, CF. Liu (nanjing, China)
Efficacy of melatonin in patients with insomnia and Parkinson’s disease

A. Domínguez-García, DR. Aguila-Godinez, AA. Herrera-Ruiz, EC. Santiago-Delacruz, LG. Lira-Juárez, MAG. Medrano-Delgado, MA. Ruiz-Mafud, AJ. Hernández-Medrano, AY. Regalado-Mustafá, DP. Romero-Terán, MF. Medina-Pérez, GI. Cerda-Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez-Armesto, A. Abundes-Corona, A. Alcocer-Salas, K. Talavera-Lagunas (CDMX, Mexico)
Efficacy of perampanel in paroxysmal kinesigenic dyskinesia

Z. Li, X. Huang, L. Cao (Shanghai, China)
Efficacy of subthalamic nucleus deep brain stimulation in Parkinson’s disease: A preliminary Thailand experience

S. Rujirussawarawong, C. Kasemsuk, T. Srikijvilaikul, N. Limotai (ฺฺBangkok, Thailand)
Effort-based decision-making and neuropsychiatric symptoms before and after subthalamic nucleus deep brain stimulation in Parkinson’s disease

D. Amstutz, M. Sousa, K. Petermann, A. Botros, M. Maradan-Gachet, I. Debove, L. Lachenmayer, A. Diamantaras, J. Waskönig, C. Pollo, D. Cazzoli, T. Nef, M. Husain, P. Krack (Bern, Switzerland)
ELectronic Archimedes spiral Neural Network (ELANN)

J. Holcomb, J. Maldjian, Y. Xi, P. O’Suilleabhain, E. Louis, B. Shah (Dallas, USA)
Electronic Development of the MDS-UPDRS and MDS-NMS: Process and User Feedback

R. Fuller, M. Monje, A. Sanchez Ferro, T. Mestre, L. Chahine, K. Dujardin, C. Fitzer-Attas, S. Groppa, S. Perez-Lloret, T. Turner, J. Youn, P. Martinez-Martin, G. Stebbins (Princeton, USA)
Electrophysiological correlates of the increase in rigidity with the Froment maneuver in Parkinson’s patients

M. Yücel, T. Odorfer, D. Zeller, J. Volkmann (Würzburg, Germany)
Electrophysiological evaluation of brainstem function in patients with idiopathic normal pressure hydrocephalus

M. Todisco, E. Alfonsi, P. Prunetti, F. Valentino, R. Zangaglia, C. Pacchetti, G. Cosentino (Pavia, Italy)
Elevated plasma CREG1 levels are linked to a lower risk of Parkinson’s disease

X. Guo, R. Zhou, G. Tian, R. Li (Xi'an, China)
Emergent alpha-beta oscillations are accompanied with worsening motor symptoms in Parkinson’s disease

E. Belova, U. Semenova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Emerging treatments targeting DNA and RNA in Huntington’s disease: a review of future perspectives and current challenges

G. Lima, F. Sarmento, I. Camargo, R. Saba, S. Silva, V. Borges, H. Ferraz (São Paulo, Brazil)
Empowerment of People with Parkinson`s disease: development, testing and evaluation of a cross-sectoral, intervention-based self-management program

T. Thomsen, S. Skovbølling, M. Møller, V. Grønlund, M. Brønden, B. Biering-Sørensen (Glostrup, Denmark)
Encoding of action plans and confidence in the human basal ganglia-thalamic circuit

D. London, M. Soula, L. Pan, R. Kiani, A. Mogilner (New York, USA)
Enhanced sensitivity to bradykinesia progression using digital health technologies in early Parkinson’s disease

M. Czech, L. Yang, J. Shen, D. Badley, M. Crouthamel, T. Kangarloo, R. Dorsey, J. Adams, J. Cosman (North Chicago, USA)
Enhancement of deep sleep in people with Parkinson disease using auditory stimulation of slow waves at home

SJ. Schreiner, S. Fattinger, J. Horlacher, G. da Poian, L. Kämpf, L. Brogli, W. Karlen, R. Huber, CR. Baumann, A. Maric (Zurich, Switzerland)
Enrollment phase sensing data from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial

T. Herrington, B. Beudel, J. Ostrem, L. Almeida, A. Ramirez-Zamora, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, S. Stanslaski, L. Tonder, Y. Tan, R. Summers, A. Singer, N. Morelli, R. Raike, H. Bronte-Stewart (Boston, USA)
Epidemiological analysis of autosomal dominant chorea in Eastern Algeria

Y. Mecheri, D. Satta, F. Serradj (Constantine, Algeria)
Epidemiological, clinical and paraclinical characteristics of paroxysmal dystonia in multiple sclerosis : A study of Tunisian cohort

M. Adouania, H. Derbali, I. Bedoui, M. Messelmani, M. Ben Mahmoud, N. Ghedamsi, M. Mansour, J. Zaouali, R. Mrissa (Tunis, Tunisia)
Epidemiology of late-onset Parkinson’s disease in least-developed to Upper Middle-Income Countries: A Systematic Review and Meta-analysis

G. Pereira, N. Soares, D. Teixeira-Dos-Santos, G. Marconi, D. Friedrich, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)
Epigenetic clock acceleration is linked to earlier onset and phenoconvertion of Rapid-eye-movement sleep behavior disorder

K. Senkevich, A. Pelletier, C. Sato, A. Keil, Z. Gan-Or, A. Lang, R. Postuma, E. Rogaeva (Montreal, Canada)
Epigenetic clocks suggest accelerated ageing in isolated REM Sleep Behavior Disorder patients

L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, D. Gentilini, G. Calandra-Buonaura, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, MG. Bacalini, F. Provini (Bologna, Italy)
Epigenome-wide meta-analysis of sex-differential DNA methylation in Parkinson’s disease

T. Yang, C. Li, Q. Wei, R. Ou, Y. Cheng, K. Liu, J. Lin, Y. Xiao, H. Shang (Chengdu, China)
Episodic ataxia type 2: a previously undescribed variant in the CACNA1A gene

N. Chunga, K. Minks, P. Morrison (Rochester, USA)
Essential tremor and essential tremor plus are essentially similar on electrophysiological tremor analysis

A. Vishnoi, A. Reghu, A. Latorre, N. Thirugnanasambandam, A. Dipani, D. Biswas, A. Srivastava, K. Bhatia, R. Rajan (New Delhi, India)
Essential tremor suppression using a novel anti-tremor orthosis

W. Mugge, L. Elstgeest, M. van Ginkel, L. Pol, IJ. de Lange, N. Pambakian, A. Souza, R. Helmich, D. Kamphuis (Delft, Netherlands)
Establishing a Natural History of X-linked Dystonia Parkinsonism

P. Acuna, ML. Supnet-Wells, N. Spencer, JK. de Guzman, M. Russo, A. Hunt, C. Stephen, C. Go, S. Carr, N. Ganza-Bautista, JB. Lagarde, S. Begalan, T. Muthaupt-Buell, G. Aldykiewicz, L. Paul, L. Ozelius, C. Bragg, B. Perry, J. Green, J. Miller, N. Sharma (Roxas City, Philippines)
Estimating the Incidence of Parkinson’s Disease in Patients with Epilepsy: A Nationwide Cohort Study in South Korea

YS. Hwang, MG. Kang, MG. Lee, SW. Yeom, BS. Shin, JS. Kim, HG. Kang (Jeonju-si, Jeonbuk-do, Republic of Korea)
Estimation of global age-specific prevalence of essential tremor by literature review of population-based studies

J. Furtado, C. Lally, WD. Flanders, M. Gerbasi, N. Maserejian (Cambridge, USA)
Estrogen and progesterone influence membrane functions and glucose transporter expression in synaptosomes of different age groups of naturally menopausal rats

P. Kumar, N. Baquer (New Delhi, India)
Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results

J. Sławek, P. Bastian, A. Roszmann, J. Dulski, D. Jacewicz, J. Drzezdzon, A. Kuban-Jankowska, M. Wozniak, N. Knap, T. Bączek, L. Konieczna, M. Belka, M. Gorska-Ponikowska (Gdańsk, Poland)
Ethical considerations in person-centered Parkinson’s disease care: a cross-national comparison of patients’ perspectives

J. Stuempel, M. van Munster, B. Schmitz-Luhn, T. Mestre, C. Woopen (Bonn, Germany)
Ethnic and Gender Disparities in Access to Deep Brain Stimulation for Parkinson’s Disease Among Participants in C-OPN

I. Ojo, S. Poonja, J. Miyasaki, A. Shetty, T. Sankar, F. Ba (Edmonton, Canada)
Evaluating continuous monitoring in Parkinson’s disease through real-world, device-reported outcomes.

G. Rigas, N. Kostikis, A. Ntanis, F. Kanellos, K. Tsamis, S. Konitsiotis, D. Fotiadis (Ioannina, Greece)
Evaluating the efficacy of dextromethorphan/quinidine (DM/Q) in treating irritability in Huntington’s disease

E. Furr Stimming, S. Abdollah Zadegan, J. Patino, N. Rocha (Houston, USA)
Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)
Evaluation of blood heavy metal concentrations in patients with essential tremor

I. Korucu, A. Aksoy Gündoğdu, N. Bahtiyar (Tekirdag, Turkey)
Evaluation of cases of psychosis from opicapone safety data

L. Guedes, I. Peixoto, K. Erb-Zohar, C. Novais, M. Sampaio, C. Santos, J. Graça, V. Vuca, P. Calero, H. Gama (Coronado, Portugal)
Evaluation of Cognitive Assessment Tools in Parkinson’s Disease

L. Cao, Y. Huang (Beijing, China)
Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)
Evaluation of possible pre-motor symptoms of Parkinson’s disease in a GBA-mutation positive cohort, as well as Gaucher disease patients.

L. Brodin, P. Svenningsson (Stockholm, Sweden)
Evaluation of small extracellular vesicles derived miRNA as biomarkers for Parkinson’s disease: comparison with plasma miRNA

S. Rai, P. Bharti, R. Singh, R. Rajan, S. Kumar (New Delhi, India)
Evaluation of structural brain stem measurements for the differential diagnosis of MSA and IPD

M. Loffeld, S. Kannenberg, A. Hausmann, C. Hartmann, J. Caspers, C. Rubbert, A. Schnitzler (Düsseldorf, Germany)
Evidence of Central Autonomic Network dysfunction in orthostatic hypotension of Parkinson’s disease

L. Xavier, E. Dayan, N. Browner, M. Sklerov (Carrboro, USA)
Evoked resonant neural activity in Globus Pallidus vs. Subthalamic Nucleus of patients with Parkinson’s Disease, preliminary results

L. Branco, C. Swamy, A. Tarakad, N. Vanegas-Arroyave, I. Patel, N. Ince, A. Viswanathan (Houston, USA)
Evoking Parkinsonism in Mice by a Pharmacological Approach Combined with Targeted Viral-based Manipulations of Neuronal Ensembles

C. Agua Villa, H. Siebner, M. Rickhag (Hvidovre, Denmark)
Examining the association between adverse effects of magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor and structural connectivity using probabilistic tractography targets

E. Tsolaki, K. Fu, Z. Rifi, M. Chodakiewitz, W. Wei, N. Pouratian, A. Bari (Los Angeles, USA)
Examining the Correlation Between Multi-Spectral Diffusion Weighted Imaging Quantitative Maps and Unified Parkinson’s Disease Rating Scale Scores

I. Shelley, I. Ailes, M. Syed, K. Shivok, J. Miao, L. Krisa, F. Mohamed, R. Sergott, T. Liang, A. Sharan, M. Kogan, C. Wu, M. Alizadeh (Philadelphia, USA)
Excessive daytime sleepiness as a predictor of cognitive decline in Parkinson disease

N. Deturk, W. Dalrymple (Charlottesville, USA)
Exercise and levodopa metabolism in Parkinson disease

M. Figura, J. Giebułtowicz, A. Mrozowicz, S. Szlufik, D. Koziorowski (Warsaw, Poland)
Exercise based priming and virtual reality for optimizing neuroplasticity and balance in Parkinson’s disease.

A. Sivaramakrishnan, M. Aguirre, S. Subramanian, G. Ernst (San Antonio, USA)
Exome sequencing of 584 Chinese proband with brain calcification

ZR. Lin (Hangzhou, China)
Exome-wide and Mitogenome Sequencing of Indian Dystonia Patients

I. Singh, A. Saini, R. Rajan, A. Srivastava (DELHI, India)
Exome-wide contribution of ultra-rare variants to the genetic architecture of Parkinson’s disease and Cutaneous Malignant Melanoma

B. Bustos, T. Krainc, Z. Gan-Or, C. Cruchaga, B. Benitez, T. Bishop, H. Morris, S. Lubbe (Chicago, USA)
Exosomal α-synuclein in Multiple system atrophy and parkinson’s disease cause distinct synucleinopathies

X. Chi, L. Kou, Y. Sun, Y. Xia, T. Wang (Wuhan, China)
Expanding the clinical phenotype of ataxia associated with PMPCA mutations

E. Sanesteban Beceiro, A. Fernández Revuelta, R. García-Ramos, E. López Valdés, M. Fenollar Cortés, F. Alonso Frech (Madrid, Spain)
Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)
Expanding the spectrum of Hereditary Spastic Paraplegia: An interesting Case .

D. Joshi, S. Pattanayak, S. Parida, A. Kumar (Varanasi, India)
Experience of Quality of Life in German Persons living with Parkinson’s Disease: A Qualitative Exploration

M. van Munster, M. Stührenberg, A. Pedrosa Carrasco, D. Pedrosa (Marburg, Germany)
Experience of the LARGE-PD protocol in a health center in Buenos Aires, Argentina

N. Gonzalez Rojas, E. Gatto, I. Mata, C. Perandones, M. Inca, M. Cesarini, G. da Prat, J. Etcheverry (Buenos Aires, Argentina)
Experiences of People with Parkinson’s Disease use of a wearable technology for the management of drooling; qualitative insights from the Cue Band study

L. Dismore, K. Montague, T. Guerreiro, L. Carvalho, D. Jackson, R. Walker (Newcastle upon Tyne, United Kingdom)
Expiratory strength in Parkinson’s disease patients? Does time matter?

R. Guimaraes, F. Cendes, L. Paiva, MF. Satollo, M. Diogo, L. Durans (Campinas, Brazil)
Explainable deep learning based detection of Parkinson’s changes in MRI brain scans

M. Courtman, M. Thurston, L. Mcgavin, C. Carroll, L. Sun, E. Ifeachor, S. Mullin (Plymouth, United Kingdom)
Exploring brain mechanisms of identity attribution in presence hallucinations of Parkinsonian origin

J. Potheegadoo, N. Vehar, F. Bernasconi, C. Stucker, S. Stampacchia, O. Blanke (Geneva, Switzerland)
Exploring mitochondrial mechanisms defining Parkinson’s disease penetrance in LRRK2 G2019S neuronal cultures

S. Delcambre, J. Ghelfi, S. Hezzaz, C. Klein, J. Trinh, P. Seibler, P. Antony, S. Pereira, A. Grünewald (Esch-sur-Alzette, Luxembourg)
Exploring patient-physician communication in Parkinson’s disease management: a qualitative analysis

A. Pilotto, L. Tonges, J. Pagonabarraga (Brescia, Italy)
Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)
Exploring the Effects of Spinal Cord Stimulation for Gait Disturbances in Parkinson’s Disease

N. Vanegas-Arroyave, K. Kwei, M. Lee, C. Prakash, L. Branco, A. Tarakad, Y. Taneff, N. Ince, A. Viswanathan, B. Najafi (Houston, USA)
Exploring the effects of torsinA dysfunction in an iPSC-derived neuronal model of TOR1A dystonia

S. Wrigley, N. Seto-Salvia, R. Brownstone, T. Warner (London, United Kingdom)
Expression profile of circRNA in peripheral blood mononuclear cells of patients with Parkinson’s disease and atypical parkinsonian syndromes

S. Ravanidis, A. Bougea, A. Simistiras, M. Maniati, C. Koros, A. Simitsi, L. Stefanis, E. Doxakis (Athens, Greece)
Extended phenotypes of autosomal recessive cerebellar ataxia type 1: learn from a novel mutation of SYNE1 gene

TL. Lee, CY. Chien, YT. Sun (Tainan, Taiwan)
Extent of cognitive impairment in Parkinson`s disease with Covid-19

B. Muminov, E. Abduqodirov, R. Matmurodov, K. Khalimova (Tashkent, Uzbekistan)
Eye tracking paradigm to identify disease-specific behavioral biomarkers in neurodegeneration

M. Habibi, B. Coe, D. Brien, H. Riek, A. Janzen, W. Oertel, D. Munoz (Marburg, Germany)